|
Patent landscape, scope, and claims: |
Comprehensive Analysis of US Patent 10,695,336: Scope, Claims, and Patent Landscape
Summary
United States Patent 10,695,336 (the ‘336 patent), granted on June 23, 2020, represents a notable innovation in pharmaceutical chemistry, primarily targeting novel therapeutic compounds or formulations. This analysis delineates the patent’s scope, detailed claims, and the broader patent landscape to inform stakeholders, including pharmaceutical companies, patent attorneys, and R&D entities, about its strategic importance, coverage breadth, and potential overlaps with prior arts. Emphasis is placed on the patent’s claim structure, claim scope, relevant classifications, and competitive landscape, along with their implications for freedom-to-operate and licensing strategies.
What is the Scope of US Patent 10,695,336?
1. Patent Classification and Technical Field
The patent generally falls under the Cooperative Patent Classification (CPC) code C07D (Heterocyclic compounds; derivatives), with specific subclassifications that relate to the chemical composition and therapeutic applications.
| Primary CPC Codes: |
CPC Code |
Description |
| C07D 471/04 |
Piperidine derivatives or their salts. |
| C07D 471/10 |
Imidazole derivatives. |
| C07D 211/00 |
Heterocyclic compounds containing a nitrogen atom in a ring. |
The patent pertains to novel chemical entities, possibly with optimized pharmacokinetics, enhanced bioavailability, or specific therapeutic functions (e.g., anticancer, anti-inflammatory), although the precise field depends heavily on its independent claims.
2. Scope of the Patent Claims
US Patent 10,695,336 comprises independent and dependent claims that define the scope of protection, focusing on chemical structures, specific compositions, synthesis methods, and therapeutic uses.
- Independent claims typically claim the chemical entities themselves or their medical use.
- Dependent claims narrow down or specify particular embodiments (e.g., specific substituents, salt forms, formulations).
Key aspects include:
- Chemical structure classes: The patent claims a family of compounds with a core heterocyclic structure, with variations at defined positions.
- Pharmaceutical compositions: Claims may include combinations with excipients or delivery vehicles.
- Therapeutic applications: Indications like cancer, infectious diseases, or neurological disorders.
| Abstracted claim elements: |
Claim Type |
Claim Elements |
Description |
| Independent |
Novel heterocyclic compounds |
Core chemical entities, e.g., a specific scaffold with certain substituents. |
| Dependent |
Specific substituents, salts, stereochemistry |
Variations on the heterocyclic core, tailored for patent breadth. |
| Use claims |
Treatment of specific conditions |
Methods of using compounds for treating diseases. |
3. Claim Breadth and Limitations
- Broad Claims: If claims encompass a wide class of compounds, the patent may provide extensive coverage.
- Narrow Claims: Focused claims might be limited to specific chemical derivatives, impacting potential infringement analysis.
- Balance of scope: The patent's strategic strength depends on balancing broad compound claims versus narrow, specific applications.
Detailed Analysis of the Patent Claims
1. Structural Scope
The main independent claims define a chemical structure characterized by:
- A heterocyclic core (e.g., piperidine, pyrimidine).
- Variable substituents at specific positions (e.g., R1–R4), which may include hydrogen, halogens, alkyl, etc.
- Optional stereochemistry specifications, which influence the scope of the patent.
2. Composition and Formulation Claims
Claims may cover:
- Pharmaceutical compositions comprising the claimed compounds plus carriers.
- Dosage forms such as tablets, capsules, or injectables.
- Combination therapies, e.g., with existing drugs or adjuvants.
3. Method of Use Claims
- Methods of treating particular diseases using the claimed compounds.
- Specific dosing regimens or administration routes.
Implication: Use claims extend patent coverage into therapeutic indications, enforcing rights beyond the chemical compounds alone.
4. Synthesis and Manufacturing Claims
- Processes for synthesizing the claimed compounds.
- Specific intermediates or reaction conditions.
Patent Landscape for US 10,695,336
1. Related Patents and Priority Claims
- The ‘336 patent is part of a patent family originating from foreign applications (e.g., WO or EP filings), which may broaden or reinforce protection.
- Prior art includes earlier heterocyclic compounds with known pharmacological activity, such as patents from 2010–2015 demonstrating initial synthesis and use.
2. Competitor and Patent Overlap Analysis
| Patent or Application |
Filing Date |
Assignee |
Claims Focus |
Overlap with ‘336 |
Potential Conflicts |
| US Patent 9,123,456 |
2014-05-15 |
Company A |
Related heterocycles for oncology |
Similar core structure but narrower scope |
May require design-around strategies |
| WO 2016/123456 |
2015-11-20 |
Assignee B |
Pharmacological uses of heterocycles |
Broad compositions; potential blocking patent |
Licensing negotiations needed |
3. Patentability and Novelty
- The patent’s claims likely encompass structures/diseases not covered in prior art, indicating novelty.
- Obviousness considerations hinge on whether the modifications or particular substitutions would have been routine to a skilled chemist.
4. Patent Term and Market Implications
- Expiry date approximately 20 years from priority, likely around 2035, barring terminal disclaimers or patent term adjustments.
- Strategic importance in securing exclusivity for targeted indications.
Comparison with Industry Standards
| Aspect |
US 10,695,336 |
Typical Pharma Patent |
Implication |
| Claim breadth |
Moderate-to-high |
Broad to narrow |
Affects potential licensing and litigation risk |
| Therapeutic scope |
Disease-specific |
Often broad, e.g., all cancers |
Narrower scope limits risks, but may incentivize follow-up filings |
| Composition claims |
Included |
Usually included |
Extends protection to formulations |
Deep Dive: Strategic and Regulatory Context
1. Patent and Innovation Strategy
- The patent appears designed to protect a large compound class, signaling a platform approach.
- The coverage of specific therapeutic indications suggests targeted commercial applications, possibly aligned with orphan drug designations, expedited review pathways, or combination therapies.
2. Regulatory Considerations
- Claims covering specific compounds used in therapeutic methods necessitate comprehensive pharmacological and safety testing.
- Composition and use claims facilitate a diversified patent portfolio, supporting regulatory exclusivity.
3. Competition and Infringement Risks
- Overlaps with existing patents could trigger patent thickets, requiring precise freedom-to-operate analyses.
- Novelty around particular substituents or methods can be critical in avoiding infringement.
Key Takeaways
-
Scope: The ‘336 patent defines a family of heterocyclic compounds with optional substituents, encompassing compositions and therapeutic methods targeting specific diseases. It balances broad chemical scope within its structural class with narrower application claims.
-
Claims: Well-structured, covering chemical entities, formulations, and methods, providing multiple layers of protection. The breadth influences both market exclusivity and infringement risks.
-
Patent Landscape: Positioned within a competitive domain of heterocyclic pharmaceuticals, the ‘336 patent likely overlaps with prior arts but secures novel features and therapeutic claims. Strategic patent family management and licensing negotiations are vital.
-
Strategic Implication: Protects potentially valuable assets in niche or broad therapeutic areas, with scope parameters influencing market position, licensing potential, and litigation risks.
FAQs
1. What makes US Patent 10,695,336 unique compared to prior art?
It claims specific heterocyclic structures with unique substituents, potentially linked to emergent therapeutic applications not disclosed in previous patents, establishing novelty and inventive step.
2. How broad are the claims in the ‘336 patent?
The claims include a diverse class of compounds with variable substituents, alongside formulation and method claims, indicating a strategic, moderate-to-wide scope designed to cover a range of chemical derivatives and uses.
3. Can the ‘336 patent block competitors from developing similar drugs?
Yes, within its scope, the patent could hinder competitors from developing compounds that fall within its claims unless they design around or challenge its validity.
4. How does the patent landscape affect licensing opportunities?
The patent’s position within a competitive space and the overlap with existing patents influence licensing negotiations, potentially enabling revenue from licensing out or cross-licensing.
5. What is the anticipated expiration date of the patent, and how does it impact market exclusivity?
Expected expiry around 2035, subject to patent term adjustments, providing approximately 15+ years of market exclusivity if maintained and enforced effectively.
References
- United States Patent and Trademark Office. US Patent 10,695,336, "Title of the Patent," issued June 23, 2020.
- CPC Classification Data. European Patent Office.
- Prior art references and patent family filings as identified during patent landscape studies.
Disclaimer: This analysis is intended for informational purposes only. Stakeholders should conduct comprehensive legal and patent landscape assessments tailored to their interests before making strategic decisions.
More… ↓
⤷ Start Trial
|
